CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica (Site 0133)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Running trials

• Active, not recruiting

  Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

  NCT03425643· Phase 3· Merck Sharp & Dohme LLC· Source